Management of Primary Infertility with Multifactor Etiology - A Case Report

    Patil Rupali Tanaji, Turlapati Vishala
    Image of study
    TLDR The treatment helped a woman with infertility become pregnant.
    The case study discusses a 27-year-old patient who had been trying to conceive for two years and was diagnosed with unexplained hyperprolactinemia & hyperemic cervix. She was treated with samshamani vati and kapikacchu churna orally, along with panchavalkal taila yonipichu. After the treatment, the patient reported a missed period and a subsequent Urine Pregnancy test confirmed her pregnancy. A dating scan further confirmed the intrauterine pregnancy. The study aimed to analyze the probable cause of her infertility and the management strategy adopted.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

      community does lowering your prolactin levels regrow hair?

      in Research/Science  10 upvotes 2 years ago
      The potential of lowering prolactin levels to regrow hair, with a reference to Bayer's drug HMI 115 which has been indicated as having this effect. Treatments mentioned include Minoxidil and Finasteride, as well as RU58841.

      community how about progesterone cream?

      in Research/Science  22 upvotes 11 months ago
      Progesterone cream might help with hair loss by inhibiting DHT production and suppressing prolactin, which can increase DHT. Some dermatologists have used progesterone for hair loss treatment, and it has been effective, sometimes combined with minoxidil, finasteride, and hydrocortisone.

      community hmi115 is coming. Prepare yourselves for what's coming

      in Technology  107 upvotes 1 year ago
      The conversation discusses HMI-115, a potential cure for hair loss. Users share mixed opinions, with some expressing skepticism and others sharing anecdotal evidence of its effectiveness, including photos of significant hair regrowth from a trial participant.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  38 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Similar Research

    5 / 742 results